Skip to Content

Orthometrix Inc OMRX

Morningstar Rating
$0.00 0.00 (9,900.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OMRX is trading at a 651% premium.
Price
$0.00
Fair Value
$8.95
Uncertainty
Extreme
1-Star Price
$6.86
5-Star Price
$7.95
Economic Moat
Dfwrjf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OMRX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$4,963.89
Volume/Avg
1,401 / 1,401

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Orthometrix Inc is engaged in the business of marketing, servicing and selling musculoskeletal product lines used in pharmaceutical research, diagnostic and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy, fitness and pain management. Its products include peripheral quantitative computed tomography x-ray scanners, whole body vibration systems, ground reaction force plate, patented bilateral arm trainer with rhythmic auditory cueing.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
7

Valuation

Metric
OMRX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
OMRX
Quick Ratio
0.01
Current Ratio
0.13
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
OMRX
Return on Assets (Normalized)
−136.75%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LxsdrnbBqsczg$181.3 Bil
Stryker Corp
SYK
YjkhkfgyyGdgg$129.3 Bil
Boston Scientific Corp
BSX
WflgytqlSfbjnt$114.2 Bil
Medtronic PLC
MDT
CvhmqypfqFvplsc$100.0 Bil
Edwards Lifesciences Corp
EW
JdqwzxkwwZrckhz$54.8 Bil
DexCom Inc
DXCM
BrkvtgdwwWcnpd$45.2 Bil
Koninklijke Philips NV ADR
PHG
YcvspshVqlmtkt$25.1 Bil
Zimmer Biomet Holdings Inc
ZBH
XdnwlrnnpQhnv$22.4 Bil
Steris PLC
STE
ZnwxjqgsjHbqgb$21.9 Bil
Align Technology Inc
ALGN
CsjxjctfNckdrpx$18.3 Bil

Sponsor Center